We have located links that may give you full text access.
Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
RATIONALE: Inflammation and vascular smooth muscle cell (VSMC) phenotypic switching are causally linked to pulmonary arterial hypertension (PAH) pathogenesis. Carbonic anhydrase inhibition (CAI) induces mild metabolic acidosis and exerts protective effects in hypoxic pulmonary hypertension (PH). Carbonic anhydrases and metabolic acidosis are further known to modulate immune cell activation.
OBJECTIVE: To evaluate if CAI modulates macrophage activation, inflammation, and VSMC phenotypic switching in severe experimental PH.
METHODS: PH was assessed in Sugen 5416/hypoxia (SU/Hx) rats after treatment with acetazolamide or ammonium chloride (NH4Cl). We evaluated pulmonary and systemic inflammation and characterized the effect of CAI and metabolic acidosis in alveolar and bone marrow-derived macrophages (BMDM). We further evaluated the treatment effects on VSMC phenotypic switching in pulmonary arteries (PAs) and pulmonary artery smooth muscle cells (PASMC) and corroborated some of our findings in lungs and PAs of PAH patients.
MEASUREMENTS AND MAIN RESULTS: Both idiopathic PAH patients and SU/Hx rats had increased expression of lung inflammatory markers and signs of PASMC de-differentiation in PAs. Acetazolamide and NH4Cl ameliorated SU/Hx-induced PH and blunted pulmonary and systemic inflammation. Expression of CA isoform 2 (Car2, CA2) was increased in alveolar macrophages from SU/Hx animals, classically (M1) and alternatively (M2) activated BMDMs, and PAH patient lungs. CAIs and acidosis had distinct effects on M1 and M2 markers in BMDMs. Inflammatory cytokines drove PASMC de-differentiation and this was inhibited by acetazolamide and acidosis.
CONCLUSION: The protective anti-inflammatory effect of acetazolamide in PH is mediated by a dual mechanism of macrophage CAI and systemic metabolic acidosis.
OBJECTIVE: To evaluate if CAI modulates macrophage activation, inflammation, and VSMC phenotypic switching in severe experimental PH.
METHODS: PH was assessed in Sugen 5416/hypoxia (SU/Hx) rats after treatment with acetazolamide or ammonium chloride (NH4Cl). We evaluated pulmonary and systemic inflammation and characterized the effect of CAI and metabolic acidosis in alveolar and bone marrow-derived macrophages (BMDM). We further evaluated the treatment effects on VSMC phenotypic switching in pulmonary arteries (PAs) and pulmonary artery smooth muscle cells (PASMC) and corroborated some of our findings in lungs and PAs of PAH patients.
MEASUREMENTS AND MAIN RESULTS: Both idiopathic PAH patients and SU/Hx rats had increased expression of lung inflammatory markers and signs of PASMC de-differentiation in PAs. Acetazolamide and NH4Cl ameliorated SU/Hx-induced PH and blunted pulmonary and systemic inflammation. Expression of CA isoform 2 (Car2, CA2) was increased in alveolar macrophages from SU/Hx animals, classically (M1) and alternatively (M2) activated BMDMs, and PAH patient lungs. CAIs and acidosis had distinct effects on M1 and M2 markers in BMDMs. Inflammatory cytokines drove PASMC de-differentiation and this was inhibited by acetazolamide and acidosis.
CONCLUSION: The protective anti-inflammatory effect of acetazolamide in PH is mediated by a dual mechanism of macrophage CAI and systemic metabolic acidosis.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app